Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Liver Diseases, Alcoholic D008108 13 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Myocardial Infarction D009203 21 associated lipids
Occupational Diseases D009784 42 associated lipids
Osteomalacia D010018 5 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Parkinson Disease D010300 53 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Gulick AM et al. Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. 2000 Biochemistry pmid:10769114
Hubbard BK et al. Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coli. 1998 Biochemistry pmid:9772162
Tiwari P et al. Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. 2016 Biochimie pmid:26655363
Ferioli A et al. Alteration of steroid hormone sulfation and D-glucaric acid excretion in lead workers. 1989 Jul-Sep Biol Trace Elem Res pmid:2484601
Singh J and Gupta KP Calcium glucarate prevents tumor formation in mouse skin. 2003 Biomed. Environ. Sci. pmid:12747003
Fujii Y et al. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). 2000 Biomed. Pharmacother. pmid:10759292
Conner TA et al. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose. 2012 Biometals pmid:22706571
Pai AB et al. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. 2011 Biometals pmid:21229380
Shiue E et al. Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. 2015 Biotechnol. Bioeng. pmid:25258165
Adzharov D et al. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats]. 1989 Biull Eksp Biol Med pmid:2914170
Ageeva TA and ShkurupiÄ­ VA [Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate]. 1994 Biull Eksp Biol Med pmid:7522618
Bhandal N and Russell R Intravenous versus oral iron therapy for postpartum anaemia. 2006 BJOG pmid:17004982
Perelló MF et al. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. 2014 BJOG pmid:24423186
WHITE LP et al. The immediate hematologic effects of intravenous saccharated iron oxide. 1952 Blood pmid:14953947
HOLLY RG Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology. 1951 Blood pmid:14869375
Breymann C Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. 2002 Nov-Dec Blood Cells Mol. Dis. pmid:12547241
Price E et al. A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. 2014 Blood Cells Mol. Dis. pmid:25065855
Eiselt J et al. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. 2006 Blood Purif. pmid:17077626
Breborowicz A et al. Intravenous iron sucrose changes the intraperitoneal homeostasis. 2009 Blood Purif. pmid:19325240
Li H and Wang SX Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. 2008 Blood Purif. pmid:18212498
Gemici C et al. Is there any role of intravenous iron for the treatment of anemia in cancer? 2016 BMC Cancer pmid:27542823
Iversen C et al. The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. 2007 BMC Evol. Biol. pmid:17439656
Rodionov DA et al. Genomic encyclopedia of sugar utilization pathways in the Shewanella genus. 2010 BMC Genomics pmid:20836887
Dong T and Schellhorn HE Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933. 2009 BMC Genomics pmid:19650909
Vindal V et al. GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. 2007 BMC Genomics pmid:17714599
Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. 2009 BMC Med Genomics pmid:19133145
Di Nocera PP et al. Genome organization of epidemic Acinetobacter baumannii strains. 2011 BMC Microbiol. pmid:21985032
Barraclough KA et al. Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). 2009 BMC Nephrol pmid:19635169
Manley HJ and Grabe DW Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study. 2004 BMC Nephrol pmid:14718064
Pollak VE et al. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. 2009 BMC Nephrol pmid:19245700
Shimizu Y et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. 2009 Bone pmid:19555782
Spencer-Peet J et al. Urinary d-glucaric acid excretion and serum gamma-glutamyl transpeptidase activity in alcoholism. 1975 Br J Addict Alcohol Other Drugs pmid:2272
Muñoz M et al. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. 2012 Br J Anaesth pmid:22337966
Basora M et al. Optimizing preoperative haemoglobin with intravenous iron. 2013 Br J Anaesth pmid:23404979
Bisbe E et al. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. 2011 Br J Anaesth pmid:21841061
Lecamwasam DS Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man. 1975 Br J Clin Pharmacol pmid:1234021
Lecamwasam DS et al. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. 1975 Br J Clin Pharmacol pmid:1234506
Ohnhaus EE et al. Enzyme induction and renal function in man. 1977 Br J Clin Pharmacol pmid:843422
Jackson L et al. The features of hepatic enzyme induction with glutethimide in man. 1978 Br J Clin Pharmacol pmid:728322
Latham AN Effect of data transformation on t-test sensitivity. 1978 Br J Clin Pharmacol pmid:728324
Tokola O et al. Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. 1975 Br J Clin Pharmacol pmid:786355
Labadarios D et al. The effects of chronic drug administration on hepatic enzyme induction and folate metabolism. 1978 Br J Clin Pharmacol pmid:23138
Ohnhaus EE et al. The effect of enzyme induction on diazepam metabolism in man. 1979 Br J Clin Pharmacol pmid:42427
Park BK Assessment of the drug metabolism capacity of the liver. 1982 Br J Clin Pharmacol pmid:6128018
Boase S and Miners JO In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. 2002 Br J Clin Pharmacol pmid:12445028
Fuchs W et al. Lansoprazole does not affect the bioavailability of oral contraceptives. 1994 Br J Clin Pharmacol pmid:7833230
Heinemeyer G et al. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy. 1986 Br J Clin Pharmacol pmid:2868749
Németh I and Szeleczki T Enhanced drug metabolism and renal dysfunction. 1981 Br J Clin Pharmacol pmid:7213515
Ylikallio A and Sotaniemi EA Drug metabolism and liver function after methyldopa withdrawal. 1980 Br J Clin Pharmacol pmid:7426273
Perucca E et al. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. 1980 Br J Clin Pharmacol pmid:7437261
Price DE et al. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. 1986 Br J Clin Pharmacol pmid:3567022
Perucca E et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. 1984 Br J Clin Pharmacol pmid:6435654
Makki KA et al. Overnight urine specimens for the determination of D-glucaric acid excretion in man. 1979 Br J Clin Pharmacol pmid:486295
Perucca E et al. The comparative enzyme-inducing properties of antiepileptic drugs [proceedings]. 1979 Br J Clin Pharmacol pmid:444364
Oxley J et al. Lack of hepatic enzyme inducing effect of sodium valproate. 1979 Br J Clin Pharmacol pmid:385027
Barot MH et al. Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy. 1978 Br J Clin Pharmacol pmid:687505
Stevens PM et al. Urinary D-glucaric acid and oral contraceptives. 1978 Br J Clin Pharmacol pmid:656297
Henry DA et al. The [14C]-aminopyrine breath test. A comparison of different forms of analysis. 1979 Br J Clin Pharmacol pmid:533576
May G Tetrachlorodibenzodioxin: a survey of subjects ten years after exposure. 1982 Br J Ind Med pmid:6121580
Martin JV Lipid abnormalities in workers exposed to dioxin. 1984 Br J Ind Med pmid:6232943
Edwards JW and Priestly BG Sister chromatid exchanges in lymphocytes of petroleum retailers. 1993 Br J Ind Med pmid:8435347
Moretto A and Lotti M Exposure to toluene increases the urinary excretion of D-glucaric acid. 1990 Br J Ind Med pmid:2310708
Edwards TJ et al. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. 2009 Br J Surg pmid:19731228
Simpson JA et al. Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069594
Ranganathan P and Pramesh CS Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128). 2010 Br J Surg pmid:20069595
Hunter J et al. Altered calcium metabolism in epileptic children on anticonvulsants. 1971 Br Med J pmid:5115570
Maxwell JD et al. Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction? 1972 Br Med J pmid:5008482
NISSIM JA Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations. 1954 Br Med J pmid:13115719
Roberts C et al. Glutethimide and enzyme induction. 1976 Br Med J pmid:990872
BOYLAND E et al. Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds. 1957 Br. J. Cancer pmid:13510516
Okada S et al. Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. 1989 Br. J. Cancer pmid:2803947
Beshara S et al. Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. 2003 Br. J. Haematol. pmid:12614222
Perewusnyk G et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. 2002 Br. J. Nutr. pmid:12117422
Laidlaw M et al. Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial. 2010 Breast Cancer (Auckl) pmid:21234288
Kimbrough RD The epidemiology and toxicology of TCDD. 1984 Bull Environ Contam Toxicol pmid:6240288
Sartor P and Cohere G [Iron saccharate capture by rat uterus epithelium. Experimental study with respect to hormonal status]. 1973 C. R. Seances Soc. Biol. Fil. pmid:4794498
Hornez JP et al. [Demonstration of different metabolic pathways starting with glucose or fructose in Rhizobium meliloti]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:11894
Hoffmann D [Role of phagocytosis and soluble antibacterial factors in experimental immunization of Locusta migratoria]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:821627
DEVOE RW and MOSES LE Iron therapy in pregnancy; a comparative study of various modes. 1954 Calif Med pmid:13209356
Karkouti K et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. 2006 Can J Anaesth pmid:16371604
CAMERON DG et al. Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity. 1951 Can Med Assoc J pmid:14792459
CAMERON DG et al. Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route. 1951 Can Med Assoc J pmid:14792458
Latham AN et al. Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man. 1976 Can. J. Physiol. Pharmacol. pmid:991005
Latham AN and Sweeney GD Binding of anticonvulsant drugs to cytochrome P-450: correlation with evidence of induction of hepatic microsomal enzymes. 1976 Can. J. Physiol. Pharmacol. pmid:1021219
Perek N et al. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. 2005 Cancer Biother. Radiopharm. pmid:16114987
Schmittgen TD et al. Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants. 1992 Cancer Chemother. Pharmacol. pmid:1586977
Walaszek Z et al. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. 1997 Cancer Detect. Prev. pmid:9101079
Walaszek Z Potential use of D-glucaric acid derivatives in cancer prevention. 1990 Cancer Lett. pmid:2208084
Walaszek Z et al. Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland. 1990 Cancer Lett. pmid:2302696
Walaszek Z et al. Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis. 1986 Cancer Lett. pmid:3768860
Oredipe OA et al. Effects of calcium glucarate on the promotion of diethylnitrosamine-initiated altered hepatic foci in rats. 1987 Cancer Lett. pmid:3690519
Wang CY and Hayashida S Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats. 1984 Cancer Lett. pmid:6548659
Kowalczyk MC et al. Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. 2010 Cancer Prev Res (Phila) pmid:20103723
Newman MA et al. Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine. 1990 Cancer Res. pmid:2334930
Liddil JD et al. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells. 1989 Cancer Res. pmid:2713856
Steele VE et al. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. 1990 Cancer Res. pmid:2138505
Minami D et al. Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. 2015 Cancer Sci. pmid:26211743
Palmer K et al. Review of available intravenous iron preparations in hemodialysis. 2013 Apr-Jun CANNT J pmid:24069699
Denton TT et al. Characterization of D-glucaric acid using NMR, X-ray crystal structure, and MM3 molecular modeling analyses. 2011 Carbohydr. Res. pmid:22015400
Herd JK et al. Synthesis of L-idaro-1,4-lactone, an inhibitor of alpha-L-idosiduronase. 1982 Carbohydr. Res. pmid:7055824